Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.AbCellera Biologics Inc. (ABCL) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?
AbCellera Biologics Eyes Phase 3 for Hot-Flash Drug After Promising Midstage Results
AbCellera Biologics Inc. (ABCL) Q3 2026 Earnings Call Transcript
What AbCellera Biologics (ABCL) Said on Its Q3 Earnings Call
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
AbCellera Reports Q3 2026 Business Results
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Rating of “Moderate Buy” from Analysts
ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026
BlackRock Inc. Makes New Investment in AbCellera Biologics Inc. $ABCL
What'sGoing On With AbCellera Biologics Stock On Tuesday?
Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
What's Going on With AbCellera Biologics Stock On Wednesday?
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Investors Buy Large Volume of AbCellera Biologics Call Options (NASDAQ:ABCL)
Already premium?